XOMA Stock (NASDAQ:XOMA)


Chart

Previous Close

$21.49

52W Range

$20.87 - $35.00

50D Avg

$25.82

200D Avg

$27.10

Market Cap

$247.32M

Avg Vol (3M)

$41.02K

Beta

1.00

Div Yield

$2.16 (2.23%)

XOMA Company Profile


XOMA Corporation operates as a biotechnology royalty aggregator in Europe, the United States, and the Asia Pacific. The company engages in helping biotech companies for enhancing human health. It acquires the potential future economics associated with pre-commercial therapeutic candidates that have been licensed to pharmaceutical or biotechnology companies. The company focuses on early to mid-stage clinical assets primarily in Phase 1 and 2 with commercial sales potential that are licensed to partners. It has a portfolio with approximately 70 assets. XOMA Corporation was incorporated in 1981 and is headquartered in Emeryville, California.

Show More

Industry

Biotechnology

Sector

Healthcare

Exchange

NASDAQ

ADR

-

Country

US

Employees

13

IPO Date

Jun 06, 1986

Website

XOMA Performance


Latest Earnings Call Transcripts


Q4 16Mar 17, 17 | 5:00 PM
Q4 15Mar 10, 16 | 5:00 PM
Q3 15Nov 06, 15 | 5:00 PM

Peer Comparison


TickerCompany
DYNDyne Therapeutics, Inc.
ACHLAchilles Therapeutics plc
CELCCelcuity Inc.
CRNXCrinetics Pharmaceuticals, Inc.
RVMDRevolution Medicines, Inc.
STOKStoke Therapeutics, Inc.
PASGPassage Bio, Inc.